NIH Clinical Center: Search the Studies

Search the Studies

47 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute
000187-EI	Adaptive Optics Imaging of Outer Retinal Diseases	Recruitment has not started	21-125 Years	NEI
000108-EI	An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4	Participants currently recruited/enrolled	10-125 Years	NEI
000078-EI	Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational Study	Participants currently recruited/enrolled	18-125 Years	NEI
20-EI-0163	Oral Metformin for Treatment of ABCA4 Retinopathy	Participants currently recruited/enrolled	12-125 Years	NEI
20-EI-0052	A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration	Participants currently recruited/enrolled	55-125 Years	NEI
20-EI-0026	An Observational Cross-Sectional Study of Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease	Participants currently recruited/enrolled	5-125 Years	NEI
20-EI-0004	Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial	Participants currently recruited/enrolled	13-125 Years	NEI
19-EI-0056	A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures	Participants currently recruited/enrolled	12-125 Years	NEI
19-EI-0045	A Sub-Study to the Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) (NTMT-01/02E) to Provide the Renexus Implant to Participants who Contributed a Single Eye Randomized to the Sham Procedure in the	Enrolling by Invitation	21-80 Years	NEI
18-EI-0142	A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis	Completed Study; data analyses ongoing	18-125 Years	NEI
18-EI-0068	An Investigation of Vitamin A Palmitate Supplementation in Patients with Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation	Participants currently recruited/enrolled	50-125 Years	NEI
18-EI-0067	An Investigation of Vitamin A Palmitate Supplementation in Patients with Age-Related Macular Degeneration (and without reticular pseudodrusen) and Delayed Dark Adaptation	Participants currently recruited/enrolled	50-125 Years	NEI
18-EI-0055	A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2	No longer recruiting/follow-up only	21-79 Years	NEI
18-EI-0046	Perception, Sensation, Cognition and Action in Humans	Participants currently recruited/enrolled	18-65 Years	NEI
17-EI-0136	Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)	Enrolling by Invitation	21-90 Years	NEI
17-EI-0112	A Long-term Follow-up Study of Participants Enrolled in 11-EI-0147: Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration (DA_AMD)	Participants currently recruited/enrolled	50-125 Years	NEI
17-EI-0071	AMD Ryan Initiative Study	Participants currently recruited/enrolled	55-125 Years	NEI
17-EI-0008	The Natural History of Geographic Atrophy Associated with Age-Related Macular Degeneration	Participants currently recruited/enrolled	55-125 Years	NEI
16-EI-0169	A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis	Completed Study; data analyses ongoing	18-125 Years	NEI
16-EI-0159	A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab	Completed Study; data analyses ongoing	18-99 Years	NEI
16-EI-0134	Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders	Participants currently recruited/enrolled	0-125 Years	NEI
16-EI-0104	Clinical and Molecular Studies in Families with Inherited Eye Disease	Participants currently recruited/enrolled	4-125 Years	NEI
16-EI-0090	Natural History of Spinocerebellar Ataxia Type 7 (SCA7)	Participants currently recruited/enrolled	12-125 Years	NEI
16-EI-0046	Uveitis/Intraocular Inflammatory Disease Biobank (iBank)	Participants currently recruited/enrolled	8-125 Years	NEI
16-EI-0024	Rod and Cone Mediated Function in Retinal Disease	Participants currently recruited/enrolled	5-125 Years	NEI
15-EI-0202	Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration	No longer recruiting/follow-up only	55-125 Years	NEI
15-EI-0128	The Genetics of Inherited Eye Disease	Participants currently recruited/enrolled	0-125 Years	NEI
15-EI-0038	A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis	Participants currently recruited/enrolled	18-125 Years	NEI
15-EI-0020	Adaptive Optics Retinal Imaging	Participants currently recruited/enrolled	12-125 Years	NEI
14-EI-0171	The Focal Electro-Oculogram in Macular Disease	Completed Study; data analyses ongoing	10-125 Years	NEI
14-EI-0064	Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions	Participants currently recruited/enrolled	0-125 Years	NEI
13-EI-0072	Microbiome and Ocular Inflammatory Disease	Clinical hold/Recruitment or enrollment suspended	18-125 Years	NEI
13-EI-0049	Genetics of Uveal Coloboma	Participants currently recruited/enrolled	1-125 Years	NEI
12-EI-0203	Natural History of ABCA4-Related Retinopathies	No longer recruiting/follow-up only	12-125 Years	NEI
12-EI-0042	NEI Intramural Biorepository for Retinal Diseases	Participants currently recruited/enrolled	2-125 Years	NEI
11-EI-0264	A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions	Completed Study; data analyses ongoing	18-125 Years	NEI
11-EI-0263	A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions	Completed Study; data analyses ongoing	18-125 Years	NEI
11-EI-0245	Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls	Participants currently recruited/enrolled	1-125 Years	NEI
11-EI-0147	Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration	Participants currently recruited/enrolled	50-125 Years	NEI
10-EI-0140	Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity, with Evaluation of the ABCA4 Gene	Participants currently recruited/enrolled	18-125 Years	NEI
08-EI-0102	Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants	Participants currently recruited/enrolled	2-125 Years	NEI
08-EI-0043	Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up	No longer recruiting/follow-up only	50-125 Years	NEI
08-EI-0031	Visual Motor Coordination	Participants currently recruited/enrolled	18-125 Years	NEI
07-EI-0213	LI/NEI Repository	Completed Study; data analyses ongoing	0-125 Years	NEI
06-EI-0236	National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases	No longer recruiting/follow-up only	2-125 Years	NEI
06-EI-0068	The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease	Completed Study; data analyses ongoing	18-125 Years	NEI
03-EI-0033	X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies	Participants currently recruited/enrolled	1-125 Years	NEI